Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial

被引：0
作者：
Jürgen Behr
Petra Neuser
Antje Prasse
Michael Kreuter
Klaus Rabe
Carmen Schade-Brittinger
Jasmin Wagner
Andreas Günther
机构：
[1] University of Munich (LMU) and Asklepios Fachkliniken München-Gauting,Department of Internal Medicine V, Comprehensive Pneumology Center
[2] Philipps University of Marburg,Coordinating Center for Clinical Trials
[3] Hannover Medical School,Department of Respiratory Medicine
[4] University of Heidelberg,Department of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik
[5] Lungenclinic Grosshansdorf and University of Kiel,Department of Internal Medicine II
[6] University of Giessen-Marburg Lung Center,undefined
[7] Justus-Liebig University Giessen,undefined
[8] AGAPLESION Lung Clinic Waldhof-Elgershausen,undefined
来源：
BMC Pulmonary Medicine | / 17卷
关键词：
Oral Pirfenidone; Conventional Anti-inflammatory Therapy; Chronic Hypersensitivity Pneumonitis; Interstitial Lung Disease (ILD); Idiopathic Pulmonary Fibrosis (IPF);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 155 条
  • [1] Noble PW(2011)Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 1760-1769
  • [2] Albera C(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-2092
  • [3] Bradford WZ(2016)Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Eur Respir J 47 243-253
  • [4] Costabel U(2014)Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2071-2082
  • [5] Glassberg MK(2009)Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement Eur Respir J 33 882-896
  • [6] Kardatzke D(2009)Lung disease related to collagen vascular disease J Thorac Imaging 24 299-309
  • [7] King TE(2013)An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 188 733-748
  • [8] Lancaster L(2008)Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time Radiology 247 251-259
  • [9] Sahn SA(2012)Immunopathology, diagnosis, and management of hypersensitivity pneumonitis Semin Respir Crit Care Med 33 543-554
  • [10] Szwarcberg J(2013)Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology J Clin Pathol 66 896-903
12345678910